ʻO ka piʻi nui ʻana o nā maʻi cardiovascular a puni ka honua i alakaʻi i nā hoʻomohala koʻikoʻi i ka mālama naʻau. I waena o ia mau mea, ʻo ka hoʻonui ʻana i ka hoʻohana ʻana i nā nitroglycerin sprays i manaʻo ʻia ʻo ia kekahi o nā ala lapaʻau kaulana loa.
ʻO ka maʻi naʻau coronary kekahi o nā kumu nui o ka morbidity a me ka make ma waena o nā maʻi naʻau. ʻO kēia maʻi ke kumu nui o ka angina pectoris, a i ʻole ka ʻeha ʻeha o ka umauma, ma muli o ka paʻa ʻana o nā aʻa. No ka hoʻopau ʻana i ka ʻehaʻeha, ke piʻi nui nei ka hoʻohana ʻana i ka nitroglycerin sprays.
ʻO ka hapa nui o ka heluna kanaka maʻi puʻuwai honua i ʻike ʻole ʻia no ka angina pectoris. Wahi a FMI, ʻo kēia waihona heluna kanaka i ʻike ʻole ʻia ka mea e hiki ai ke hoʻonui i nā manaʻo ulu no ka mākeke ma nā makahiki wānana e hiki mai ana.
Hoʻoiho i ke kope kope o ka hōʻike: https://www.futuremarketinsights.com/reports/sample/rep-gb-12620
ʻO nā mea nui e lawe ʻia mai ka haʻawina ʻo Nitroglycerin Sprays Study
- Ua ʻōlelo ʻo ʻAmelika ʻĀkau e mālama i ka hegemony mākeke, e hopu ana ma luna o ʻelua hapalima o ka ʻāpana kālā
- ʻO ka prophylaxis o ka angina pectoris e hoʻomau i ka māhele nui, e hoʻonui mau ana ma 4.1% CAGR mai 2020-2030
- Ma ke ala hāʻawi, ua mākaukau ke kūʻai aku i nā lāʻau lapaʻau pūnaewele e ʻike i ka hoʻonui ʻia ʻana ma muli o ka maʻi maʻi maʻi a me ka hoʻonui ʻana i ka heluhelu digital.
- ʻO 90 mika mika / ʻōmole hiki ke hoʻomau i ka koho i makemake nui ʻia, e hoʻopaʻa inoa i kahi index o 1.4
- E hoʻonui mau ʻia ka mākeke nitroglycerin lāʻau lapaʻau honua, e kākau inoa ana i kahi CAGR o 4.2%
E noi i kahi TOC piha o kēia hōʻike me nā helu: https://www.futuremarketinsights.com/toc/rep-gb-12620
Kaʻikepili paʻakikī
Hoʻohui nui ʻia ka mākeke lāʻau lapaʻau nitroglycerin sprays honua, me ka loaʻa ʻana o nā mea pāʻani kaulana ʻehā: Perrigo Company Plc., Evus Health Solutions LLC., G. Pohl-Boskamp GmbH & Co. a me Akrimax Pharmaceuticals LLC. Kuhi nui kēia mau mea pāʻani i ka hoʻoikaika ʻana i ka portfolio ma ka hoʻokomo ʻana i nā huahana hou i ka mākeke.
No ka laʻana, i Kepakemapa 2020, ua hoʻolauna ʻo Perrigo Company Inc. i ka hōʻailona hale kūʻai e like me Voltaren® Arthritis Pain Reliever ma nā hale kūʻai lāʻau lapaʻau. ʻO ia ka palapala noi lāʻau hou hou i pōkole (ANDA) e loaʻa i ka ʻae ʻia ʻo US FDA.
I ka makahiki 2006, ua loaʻa iā Evus Health Solutions ka ʻae mai ka FDA e hoʻomaka i ka NitroMist® Nitroglycerin Lingual Aerosol Spray. ʻO ka mea hana he nitrate vasodilator i hōʻike ʻia no ka hoʻomaha nui ʻana i kahi hoʻouka a i ʻole prophylaxis acute o angina pectoris. Loaʻa kēia 400 mcg no ka pulupulu ma 230 mika a i ʻole 90 mika mika no ka pahu.
ʻO G-Pohl-Boskamp GmbH & Co. kekahi o nā mea hana lāʻau kūʻokoʻa kūʻokoʻa kūleʻa loa o Kelemania. Loaʻa i kāna kōpili huahana kahi ʻano huahana no kekahi mau kūlana maʻi. I kēia hihia, hana ka hui i ka Nitrolingual Pumpspray i loaʻa i 60 a me 200 mika mika no ka pahu.
E nīnau iā mākou i kāu mau nīnau e pili ana i kēia hōʻike:
https://www.futuremarketinsights.com/ask-question/rep-gb-12620
Nā ʻike pili COVID-19
Ua loaʻa i ka maʻi maʻi maʻi COVID-19 ka hopena maikaʻi ʻole i ka honua holoʻokoʻa, e lawe mai ana i nā pōkole loaʻa kālā a hōʻemi i nā palena kālā. E hoʻomau ʻia ka hoʻokele waiwai lōʻihi no nā makahiki e hiki mai ana.
E pili ana i ka nitroglycerin sprays, ua manaʻo ʻia e hoʻolōʻihi ka mākeke i ka ʻoihana mālama ʻoihana, pili i ka neʻe ʻana i nā mea nui i ka hoʻopau ʻana i ka maʻi maʻi. No laila, ke hoʻopanee ʻia nei nā ʻokiʻoki koho no nā maʻi maʻi puʻuwai, e alakaʻi ana i ka palena o ka lawe ʻana o nā nitroglycerin sprays.
ʻO kēia hoʻopaneʻe ʻana i nā ʻoihana cardiovascular elective e koi ana i nā poʻe maʻi e koho i nā koho homecare. No laila, ke piʻi mau nei ka hoʻokele waha a me ka sublingual o ka nitroglycerin sprays e pale i ka hoʻouka ʻana o ka angina.
Mākeke Nitroglycerin Sprays Lapaʻau- Māhele Manaʻo
noi
- ʻO ka pale ʻana i ka Angina Pectoris
- Hoʻokuʻu i ka hoʻouka kaua (Lapaʻau)
Ka nui o ke kino
- 60 mika mika /'ōmole
- 90 mika mika /'ōmole
- 200 mika mika /'ōmole
- 230 mika mika /'ōmole
Kaha Haina
- Nā lāʻau lapaʻau lāʻau
- Nā Hale kūʻai lāʻau kūʻai
- Nā hale kūʻai lāʻau lapaʻau pūnaewele
Māhele
- ʻAmelika ʻĀkau (US & Kanada)
- ʻAmelika Latina (Brazil, Mekiko, ʻAmelika a me ke koena o Latin America)
- ʻEulopa (Kelemānia, ʻIlia, Palani, UK, Sepania, BENELUX, Rūsia a me ke koena o ʻEulopa)
- ʻĀkia Hikina (Kina, Iapana & Kolea Hema)
- ʻAsia Hema (India, Thailand, Indonesia, Malaysia a me ke koena o Asia Hema)
- Oceania (Australia & New Zealand)
- Hikina Waena & ʻApelika (GCC, ʻApelika Hema, ʻApelika ʻĀkau a me ke koena o MEA)
About Ka Makahiki Hou (FMI)
ʻO ka Future Market Insights (ESOMAR i hōʻoia ʻia i ka ʻoihana noiʻi mākeke a me kahi lālā o Greater New York Chamber of Commerce) hāʻawi i nā ʻike hohonu i nā kumu hoʻokele e hoʻokiʻekiʻe ana i ka noi ma ka mākeke. Hōʻike ia i nā manawa kūpono e makemake ai i ka ulu ʻana o ka mākeke ma nā ʻāpana like ʻole ma ke kumu o Source, Application, Sales Channel a me ka hoʻohana hope ʻana i nā makahiki 10 e hiki mai ana.
Kāhea iā mā˚ou:
Nā Hōʻikeʻike o ka Makahiki Hou
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A
ʻO Jumeirah Lakes Towers, Dubai
Aupuni ʻEmira ʻAlapia Hui Pū ʻia
He aha e lawe ʻia mai kēia ʻatikala:
- E pili ana i ka Future Market Insights (FMI)Future Market Insights (ESOMAR i hōʻoia ʻia i ka hui noiʻi mākeke a me kahi lālā o Greater New York Chamber of Commerce) hāʻawi i nā ʻike hohonu i nā kumu hoʻokele e hoʻokiʻekiʻe ana i ka noi ma ka mākeke.
- The device is a nitrate vasodilator indicated for acute relief of an attack or acute prophylaxis of angina pectoris.
- With regard to nitroglycerin sprays, the market is expected to decelerate in the professional caregiving sector, attributed to shifting priorities towards the pandemic's eradication.
